Literature DB >> 1688502

Interleukin-4 has basophilic and eosinophilic cell growth-promoting activity on cord blood cells.

C Favre1, S Saeland, C Caux, V Duvert, J E De Vries.   

Abstract

Effects of human recombinant interleukin-4 (IL-4) on cord blood cells depleted of T cells and monocytes were tested in colony assays and liquid cultures. IL-4 did not induce colony formation in semisolid medium, but enhanced generation of basophil colonies induced by conditioned medium (CM) of the bladder carcinoma cell line 5637. In liquid cultures, variable degrees of basophil growth were observed in the presence of IL-3, granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF, and 5637 CM, or even with IL-4 alone, but the highest number of basophils were obtained when IL-4 was used in combination with IL-3 or 5637 CM. Progressive basophil growth was observed during 3 to 4 weeks of culturing, whereafter the numbers of basophils remained stationary for another 3 weeks. Interestingly, cord blood cell cultures performed with IL-3 contained variable percentages of eosinophils that were further enhanced in the presence of combinations of IL-3 and IL-4. These latter cultures contained approximately 50% eosinophils and 50% basophils. Kinetic studies indicated that basophils were present 7 days after onset of the cultures, whereas eosinophils did not appear before day 13. In contrast to the pronounced effects of IL-4 and 5637 CM on basophil development, relatively low numbers of eosinophils were observed under these culture conditions. Our results indicate that eosinophil and basophil development are regulated by different sets of factors, and that IL-4 has an enhancing effect of both cell lineages in association with the appropriate factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688502

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis.

Authors:  D Girard; R Paquin; A D Beaulieu
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Interleukin-4 and RANTES expression in maturing eosinophils derived from human cord blood CD34+ progenitors.

Authors:  J R Velazquez; P Lacy; S Mahmudi-Azer; B Bablitz; C D Milne; J A Denburg; R Moqbel
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

4.  Growth factors controlling interleukin-4 action on hematopoietic progenitors.

Authors:  A Ferrajoli; T F Zipf; M Talpaz; E A Felix; Z Estrov
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

5.  Effects of cyclosporin A and a rapamycin derivative (SAR943) on chronic allergic inflammation in sensitized rats.

Authors:  Paul R Eynott; Michael Salmon; Tung-Jung Huang; Timothy Oates; Paul L Nicklin; K Fan Chung
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

6.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.

Authors:  F Fossiez; O Djossou; P Chomarat; L Flores-Romo; S Ait-Yahia; C Maat; J J Pin; P Garrone; E Garcia; S Saeland; D Blanchard; C Gaillard; B Das Mahapatra; E Rouvier; P Golstein; J Banchereau; S Lebecque
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

7.  Anti-tumor effects of interleukin-4 and interleukin-5 against mouse B cell lymphoma and possible mechanisms of their action.

Authors:  H K Wu; H Hirai; K Inamori; K Kitamura; F Takaku
Journal:  Jpn J Cancer Res       Date:  1992-02

8.  Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness.

Authors:  U A Temann; G P Geba; J A Rankin; R A Flavell
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.